Health Affairs October 24, 2024
The Food and Drug Administration’s (FDA) recent authorization of FluMist for at-home administration marks the beginning of a new chapter in vaccine access and delivery. Before now, self-administered vaccines have been as elusive as they are full of promise. The FDA’s decision will be the first to allow self-administration, beginning with the 2025–26 respiratory season and will require a prescription.
Traditionally, patients received vaccinations at a physician’s office, but vaccination is becoming increasingly de-medicalized. While most young children still receive regular vaccinations in their pediatrician’s office, adolescent and adult patients are now able to access vaccines across many different settings of care. The ever-increasing role of pharmacies as vaccination sites is reflective of the shift. The home represents yet a...
Today's Sponsors
Today's Sponsor